✦ LIBER ✦

A Phase Ib/II Clinical Study on Vascular Targeting Therapy of Head and Neck Carcinoma

✍ Scribed by Marc Dellian; Sebastian Strieth; Uwe Michaelis; Kurt Naujoks; Barbara Wollenberg

Book ID: 116810849
Publisher: SAGE Publications
Year: 2005
Tongue: English
Weight: 48 KB
Volume: 133
Category: Article
ISSN: 0194-5998
DOI: 10.1016/j.otohns.2005.05.342

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical study of vascular targe

Phase I clinical study of vascular targeting fluorescent cationic liposomes in head and neck cancer

✍ Sebastian Strieth, Christoph Dunau… 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 324 KB

Palliative laser therapy for recurrent h

Palliative laser therapy for recurrent head and neck cancer: A phase II clinical study

✍ Marcos B. Paiva; Keith E. Blackwell; Romaine E. Saxton; Thomas C. Calcaterra; Pa 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 741 KB

A phase II study of primary reirradiatio

A phase II study of primary reirradiation in squamous cell carcinoma of head and neck

✍ Johannes A. Langendijk; Nicolien Kasperts; Charles R. Leemans; Patricia Doornaer 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 109 KB

A phase IB clinical and pharmacokinetic

A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck

✍ Matthew M. Cooney; Kou-Yi Tserng; Vinit Makar; R. Jeff McPeak; Stephen T. Ingall 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 233 KB

A phase II study of Imatinib for advance

A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands

✍ M. Raphael Pfeffer; Yoav Talmi; Raphael Catane; Zvi Symon; Ady Yosepovitch; Mark 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 100 KB

A phase II study of adriamycin in previo

A phase II study of adriamycin in previously untreated squamous cell carcinoma of the head and neck

✍ Melody A. Cobleigh; James H. Hill; Patricia A. Gallagher; Lawrence J. Kukla; Tho 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 2 views

Twenty patients with squamous cell carcinoma of the head and neck (SCC H/N) were treated with Adriamycin (doxorubicin) at a dosage of 60 mg/m\* at 3-week intervals. No patient had received surgery, radiation, or chemotherapy before treatment with Adriamycin. Responses were observed in 44% of 18 eval